1. Introduction {#sec1}
===============

Diabetes is becoming a serious worldwide threat to human health and rises rapidly in China recently. Pancreatic *β*-cell mass should be dynamic and can respond to physiological and pathological variations in metabolic demand on insulin production. But this ability of the endocrine pancreas seems to be attenuated in type 2 diabetes which finally leads to hyperglycemia and blood glucose fluctuations \[[@B1]--[@B3]\]. Evidence from autopsy also demonstrated that *β*-cell mass in diabetic patients is significantly reduced and its reduction is associated with increased apoptosis \[[@B4], [@B5]\]. Glucose control may become deteriorated despite intensive treatment in diabetic patients because their pancreatic beta cell mass decreased abnormally. The patients with long duration of diabetes will be prone to show a higher glucose variation \[[@B6], [@B7]\].

Intermittent high glucose (IHG) as a general phenomenon in the duration of diabetes has been suggested to be more dangerous for the development of diabetes and diabetes-related complications \[[@B8], [@B9]\]. Several lines of studies showed that blood glucose fluctuations can increase activities of protein kinase C, activate oxidative stress, promote the apoptosis of cell including the *β*-cells, and ultimately result in progressive beta cell failure and beta cell mass reduction \[[@B10], [@B12]\]. A higher apoptosis of beta cell induced by intermittent high glucose was associated with the increased oxidative stress level \[[@B13]\]. Nevertheless, the mechanism underlying the action of IHG on *β* cells has not yet been fully studied. The previous researches mostly focused on the relationship between apoptosis and IHG; in fact, in addition to cell apoptosis, the lower proliferation activity in *β* cells may be another important reason involved in the *β*-cell mass reduction \[[@B14]\].

In the present study we used an in vitro model to investigate not only the role of IHG in inducing *β*-cells apoptosis but also the effect on proliferation activity in *β*-cells and the possible mechanisms.

2. Materials and Methods {#sec2}
========================

2.1. Reagents and Antibodies {#sec2.1}
----------------------------

All reagents for cell culture were purchased from Sigma (St. Louis, MO, USA). Cell Cycle Analysis Kit and Cell counting kit-8 (CCK-8) and Reactive Oxygen Species Assay Kit and Annexin V-FITC Apoptosis Detection Kit were from Beyotime Institute of Biotechnology. Xanthine Oxidase Assay Kit was from BioVision Incorporated (Milpitas, CA, USA). 4, 6-Diamidino-2-phenylindole (DAPI) was purchased from Vector Laboratories (Burlingame, CA). Antibodies against p21 and Skp2 were purchased from Santa Cruz Biotechnology Inc. (Delaware, CA, USA). Alexa Fluor 594-conjugated goat anti-rabbit IgG and cyclinD1 antibodies were purchased from Invitrogen (Carlsbad, CA, USA). Polyclonal antibodies of p27 were purchased from Millipore (Bedford, MA, USA).

2.2. Cell Culture {#sec2.2}
-----------------

The INS-1 cells were purchased from cell repository of laboratory animal centre in Wuhan University. And then they were grown at 37°C in a humidified 5% CO~2~ atmosphere in RPMI-1640 medium (pH 7.4) supplemented with 10% fetal bovine serum. When the cells were in a synchronization state, cells were cultured, respectively, in RPMI-1640 complete medium with the normal glucose concentration (5.5 mmol/L), constant high glucose concentration (25 mmol/L), and the intermittent high glucose concentration (the rotation per 24 h in 11.1 mmol/L or 25 mmol/L) for 7days.

2.3. Determination of Apoptotic Cells {#sec2.3}
-------------------------------------

Annexin V-FITC/PI double staining was used to evaluate the cell apoptosis strictly following the procedures of Annexin V-FITC Apoptosis Detection Kit. Briefly, cells were trypsinized and resuspended at a concentration of 1 × 10^6^/mL in dilute binding buffer and labeled with 10 *μ*L of Annexin V-FITC at room temperature in the dark for 30 min; then add 5 *μ*L of PI for 5 min; 400 *μ*L of 1 × binding buffer was added into each tube later.

Flow cytometric analysis was finally performed with excitation at 488 nm as soon as possible to monitor the green fluorescence of Annexin V and the red fluorescence of DNA-bound PI.

2.4. Reactive Oxygen Species Production {#sec2.4}
---------------------------------------

Intracellular ROS generation was measured by flow cytometry using peroxide-sensitive fluorescent probe 2′,7′-dichlorofluorescein diacetate (DCFH-DA, Molecular Probes) following the method described previously \[[@B15]\]. DCFH-DA will be converted by intracellular esterases to DCFH, a nonfluorescent compound; then it is oxidized into the highly fluorescent dichlorofluorescein (DCF) in the presence of oxidant. In brief, the treated cells were harvested and incubated with 10 *μ*M of DCFH-DA for 30 min at 37°C in the dark, and after being washed twice with PBS, the fluorescent intensity of cells from different groups was analyzed by flow cytometry.

2.5. XOD Activity Assay {#sec2.5}
-----------------------

The XOD activity was measured spectrophotometrically using the Xanthine Oxidase Activity Colorimetric/Fluorometric Assay Kit \[[@B16]\]. One unit xanthine oxidase is defined as the amount of enzyme which catalyzes the oxidation of xanthine, yielding 1.0 *μ*mol of uric acid and H~2~O~2~ per minute at 25°C. Briefly, cells were trypsinized and resuspended at a concentration of 1 × 10^6^/mL with dH~2~O (400 *μ*L), then extracted with 4 volumes of the Assay Buffer, and centrifuged (16,000 ×g, 10 min) to get clear XO extract. For the positive control, add 5 *μ*L positive control solution to wells and adjust volume to 50 *μ*L/well with dH~2~O. For each well, prepare a total 50 *μ*L reaction mix containing 44 *μ*L Assay Buffer, 2 *μ*L substrate mix, 2 *μ*L enzyme mix, and 2 *μ*L OxiRed Probe. Add 50 *μ*L of the reaction mix to each well containing the H~2~O~2~ standard, positive control, and test samples and mix well. Measure the plate immediately (OD = 570 nm for colorimetric assay).

2.6. Cell Counting Kit-8 Assay for Proliferation Activity {#sec2.6}
---------------------------------------------------------

The treated INS-1 cells were cultured in Corning 96-well flat bottomed microtiter plates for 7 days. 10 *μ*L of CCK-8 was then added and incubated in a high humidity environment at 37°C and 5% CO~2~ for an hour and optical difference (OD) was read at 460 nm with a microplate reader \[[@B17]\]. The OD value represents the proliferation activity.

2.7. Cell Cycle Analysis {#sec2.7}
------------------------

Cell cycle analysis was carried out by flow cytometry according to a standard protocol. INS-1 cells were gained by centrifugation, washed with cold PBS, and fixed with cold 70% ethanol for 12 hours. Then the fixed cells were stained with PI solution consisting of 50 *μ*g/mL PI, 20 *μ*g/mL RNase A, and 0.1% Triton X-100. After 0.5 h incubation in the dark, the stained cells were detected in a FACScan flow cytometer. The distribution of cells in the different cell cycle phases was analyzed using Multicycle software (Phoenix Flow Systems, San Diego, CA). The ratio of cells in each phase of the cell cycle was determined in triplicate \[[@B18]\].

2.8. Western Blotting Analysis {#sec2.8}
------------------------------

The treated cells were lysed in protein lysis buffer (1% SDS in 25 mmol/L Tris-HCl, pH = 7.4, 1 mmol/L EDTA, 100 mmol/L NaCl, 1 mmol/L PMSF, 10 *μ*g/mL leupeptin, and 10 *μ*g/mL pepstatin). Cell lysates were frozen and thawed 3 times and were further centrifuged at 12,000 g for 10 min at 4°C to pelletize the insoluble material. The protein concentration was measured using the BCA protein assay. The total protein (20 *μ*g) from each sample was separated on 12% SDS-polyacrylamide gel and transferred to polyvinylidene fluoride (PVDF) membranes. Membranes were blocked in 5% nonfat milk and incubated with either anti-cyclinD1 (1 : 200), anti-Skp2 (1 : 100), anti-p21 (1 : 200), anti-p27 (1 : 1000) antibody, or anti-*β*-actin (1 : 2000) antibody overnight. After extensive washing, the immunocomplexes were detected using Western Blotting Luminol Reagent.

2.9. Statistical Analysis {#sec2.9}
-------------------------

Every experiment was repeated five times. All data were expressed as the mean ± S.D. of triplicate experiments. Differences between groups were tested by one-way ANOVA followed by a Student-Newman-Keuls test. And *P* values less than 0.05 were considered as statistically significant.

3. Results {#sec3}
==========

3.1. Apoptosis in INS-1 Cells Induced by Intermittent High Glucose Measured by Annexin-V/PI Staining {#sec3.1}
----------------------------------------------------------------------------------------------------

The apoptosis of INS-1 cells was determined by Annexin-V/PI staining via flow cytometry. The percentage of apoptotic cells ([Figure 1](#fig1){ref-type="fig"}) in CHG and IHG group was, respectively, 20.92 ± 3.88% and 30.67 ± 4.48%, significantly higher than the control group (normal glucose) 8.91 ± 2.92%. The apoptosis rate induced by IHG showed a statistical difference (*P* \< 0.05) compared with the CHG and control group. This result means that intermittent high glucose significantly increased the cell apoptosis compared with both normal and constant high glucose concentrations.

3.2. Intermittent High Glucose Increased Intracellular Reactive Oxygen Species Level by Enhancing the Intracellular Xanthine Oxidase Activity {#sec3.2}
---------------------------------------------------------------------------------------------------------------------------------------------

To evaluate the influence of IHG on intracellular levels of oxidative stress, we measured the intracellular reactive oxygen species level by flow cytometry using DCFH-DA fluorescence staining as described previously. As shown in [Figure 2](#fig2){ref-type="fig"}, the intracellular reactive oxygen species level in INS-1 cells exposed to CHG increased by 2-fold compared with control (normal glucose), but, the reactive oxygen species level in cells exposed to IHG significantly increased nearly by 2.63-fold compared with control. The intracellular XOD activity was measured spectrophotometrically at the same time. We found that ([Figure 3(a)](#fig3){ref-type="fig"}) the cells exposed to CHG showed a significantly increased XOD activity (0.58 ± 0.03) compared with normal glucose group (0.23 ± 0.03), while the cells exposed to IHG had the highest XOD activity (0.79 ± 0.03) and showed a statistical difference (*P* \< 0.05).

3.3. Effect of Intermittent High Glucose on Proliferation Activity in INS-1 Cells {#sec3.3}
---------------------------------------------------------------------------------

We evaluated the effect of intermittent high glucose on cell proliferation activity in INS-1 cells with the CCK-8 assay. As shown in [Figure 3(b)](#fig3){ref-type="fig"}, INS-1 cells treated with CHG showed a significantly reduced cell viability (0.67 ± 0.04) compared with normal glucose group (1.51 ± 0.14). The cells exposed to IHG showed the lowest proliferation activity and the difference was statistical (*P* \< 0.05).

3.4. Effect of Intermittent High Glucose on Cell Cycle Distribution {#sec3.4}
-------------------------------------------------------------------

To determine whether IHG regulates the cell cycle of INS-1 cells, the distribution of treated INS-1 cells in various compartments of the cell cycle was examined by flow cytometry. The ratio of cells in each phase of the cell cycle in different groups is summarized in [Figure 4](#fig4){ref-type="fig"}. Cells treated with IHG showed a marked accumulation in the G0/G1 phase and decrease in the G2/M phase compared with the normal glucose and CHG group (*P* \< 0.05).

3.5. Effect of Intermittent High Glucose on Expression of CyclinD1, Skp2, p21, and p27 Protein Levels in INS-1 Cells {#sec3.5}
--------------------------------------------------------------------------------------------------------------------

To investigate the cellular mechanism by which IHG inhibited the proliferation activity of INS-1 cells, we analyzed the expressions of cyclinD1, Skp2, p21, and p27 protein levels using Western blot analysis. The expression of cyclinD1 analyzed by Western blotting was shown in [Figure 5(a)](#fig5){ref-type="fig"}; IHG could markedly downregulate the expression of cyclinD1 compared with CHG and normal glucose group (*P* \< 0.05). As shown in [Figure 5(b)](#fig5){ref-type="fig"}, the expression of Skp2 was significantly decreased by IHG (*P* \< 0.01). Meanwhile we found that in Figures [5(c)](#fig5){ref-type="fig"} and [5(d)](#fig5){ref-type="fig"} the expressions of p27 and p21 protein level in INS-1 cells were increased by IHG obviously compared with the normal glucose group (*P* \< 0.05). These results indicate that IHG may inhibit the proliferation activity of INS-1 cells through regulating the cyclins, such as cyclinD1, Skp2, p21, and p27.

4. Discussion {#sec4}
=============

Recently, the apoptosis of pancreatic beta cells has become a major focus. There is a growing body of evidence suggesting that pancreatic beta cell mass in diabetic patients is significantly reduced which mainly resulted from the increased apoptosis. Both animal and human studies have demonstrated that increase of *β*-cell apoptosis is an important reason for insulin deficiency in T2DM, which finally leads to hyperglycemia and blood glucose fluctuations \[[@B4], [@B5], [@B19]\]. It is now clear that hyperglycemia is not only the result of *β*-cell deficiency, but also the important reason for further *β*-cell dysfunction and number reduction. Both human pancreatic islets incubated with high glucose concentrations and animal models which received hyperglycemia treatment repeatedly show an obvious increase of apoptosis \[[@B20], [@B21]\]. Although pancreatic beta cell glucose toxicity is usually characterized as an impairment of beta cell functions induced by chronic constant high glucose, more and more studies have suggested intermittent high glucose (IHG) to be more dangerous for further *β*-cell dysfunction and the development of diabetes. IHG could more easily induce human umbilical vein endothelial cells injury and promote development of diabetic chronic vascular complications compared with sustained high blood glucose (SHG) \[[@B22], [@B23]\]. IHG can induce a more significant impairment of insulin release response in rat islets and INS-1 cell than SHG; INS-1 cells exposed to IHG showed higher apoptosis and lower GSIS than SHG \[[@B24]\]. In the present study, we similarly found that a higher apoptosis rate of cultured INS-1 cells was induced by IHG compared with CHG and normal glucose. This result is in agreement with previous researches.

There are many potential mechanisms whereby blood glucose fluctuation might cause pancreatic beta cell damage. Blood glucose fluctuations can enhance activity of protein kinase C and NAD(P)H-oxidase and increase oxidative stress, which in turn induce increased apoptosis \[[@B10], [@B12], [@B11], [@B25]\]. In agreement with previous researches, the present study showed that the intracellular oxidative stress was more significantly hyperactivated under the condition of IHG than the condition of CHG. Meanwhile, the intracellular XOD activity in INS-1 cells cultured in IHG was enhanced significantly compared with CHG. We know that Xanthine oxidase (XOD), an enzyme widely distributed in mammal tissues, can catalyze metabolism of hypoxanthine to xanthine and then to uric acid in the presence of molecular oxygen accompanied with O^2−^ generation. XOD level could be upregulated in diabetes and a main source of oxidants \[[@B26]--[@B28]\]. These findings suggest that fluctuation in glycemic control could be more deleterious to the pancreatic beta cells than a constant high glucose. The intracellular oxidative stress produced by hyperactivated XOD activity might play a major role in mediating the effect of IHG.

Currently, proliferation from preexisting beta cells is considered to be a major source of newly derived pancreatic beta cells. The extent of beta cell proliferation changes over time according to the metabolic requirements; diabetes occurs when this ability of pancreatic beta cells is attenuated \[[@B14], [@B29], [@B30]\]. Hyperglycemia especially the intermittent high glucose that resulted from *β*-cell deficiency can conversely influence the *β*-cell proliferation; it has been proved that IHG could increase both cell apoptosis and inhibition of proliferation in human umbilical vein endothelial cells through NF-*κ*B pathway \[[@B23]\]. The study herein observed the similar effects of IHG on the proliferation activity of INS-1 cells. As shown in [Figure 3(b)](#fig3){ref-type="fig"}, the cells exposed to IHG showed lower cell viability compared with CHG. We also found that treatment of IHG increased accumulation of INS-1 cells in the G0/G1 phase and notably decreased the ratio of the cells in G2/M phase. Our results demonstrated that the lower proliferation activity and cell cycle arrest induced by IHG could partially be responsible for pancreatic beta cell mass reduction.

It is well documented that cell cycle is controlled by the sequential formation, activation, and inactivation of a series of cell cycle regulators, that is, cyclins, cyclin-dependent kinases (CDK), and cyclin-dependent kinase inhibitors (CKIs). CyclinD1 as positive regulators of cell cycle rises in G1 phrase and remains high until mitosis, Cdks4, 5, and 6 complexes mainly combine with the cyclin D family and function during the G0/G1-phases of the cycle \[[@B31]\]. Cyclin D1 overexpression in beta cells results in a higher rate of beta cell proliferation in vivo, consistent with a similar study performed on rat and human islets in vitro \[[@B32], [@B33]\]. A number of negative regulators also exist, the Cdk inhibitors (CDKIs), such as the CIP (Cdk-interacting protein)/KIP (kinase inhibitor protein) families including p21, p27 are involved in cyclin binding and kinase inhibitory function. Studies showed that islets from p21cip1-/- mouse treated with mitogens in vitro showed higher DNA synthesis compared with p21-expressing islets. p27 kip1 regulates beta cell proliferation by arresting the cell cycle in the adult \[[@B34]--[@B36]\]. The accurately ordered cell cycle also includes the timely degradation of many regulatory proteins via ubiquitin-mediated proteolysis; the SCF complexes represent a big family of ubiquitin ligases that determine the abundance of cell cycle regulatory proteins; Skp2 promotes the ubiquitinylation of the CDKIs, p21, and p27, thereby enhancing CDK2 activation at the G1/S border \[[@B37], [@B38]\]. Consistent with previous researches, in our study, the cells with low cell viability induced by IHG showed a decreased expression of cyclinD1 and Skp2 and an increased expression of p27 and p21. The cell cycle of INS-1 cells was blocked mainly in G0/G1 phrase.

In summary, our study simultaneously investigated the apoptosis-inducing and antiproliferative role of IHG on INS-1 cells and preliminarily revealed the possible mechanism. Chronic exposure to IHG may not only result in more effective induction of apoptosis via increasing intracellular oxidative stress produced by hyperactivated XOD activity, but also inhibit the cell viability and block the cell cycle progression through changing the expressions of cell cycle regulators. We know that the cell signal transduction pathways are more multifarious and complicated; further studies may be needed for understanding the exact signaling and mechanism, especially studies based on primary *β*-cells and the in vivo studies.
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![Determination of apoptotic cells with flow cytometry. After the treatment for 7 days, cells were collected for the detection of cell apoptosis as described previously. The percentage of apoptotic cells was shown after analysis by flow cytometry. Data were expressed as mean ± SD of three determinations. Control, normal glucose; CHG, constant high glucose; IHG, intermittent high glucose. \**P* \< 0.05, and ^Δ^ *P* \< 0.05 respectively, indicate a significant difference from controls and CHG.](JDR2014-712781.001){#fig1}

![Intracellular reactive oxygen species level of INS-1 cells with DCFH-DA staining. Images of DCFH-DA staining and data of fluorescence intensity analysis for INS-1 cells exposed to different treatment by flow cytometry were demonstrated. Control, normal glucose; CHG, constant high glucose; IHG, intermittent high glucose. \**P* \< 0.05 and ^Δ^ *P* \< 0.05, respectively, indicate a significant difference from controls and CHG.](JDR2014-712781.002){#fig2}

![The intracellular XOD activity and cell viability in INS-1 cells. XOD activity was measured spectrophotometrically using Xanthine Oxidase Activity Colorimetric/Fluorometric Assay Kit (a). The cell viability in INS-1 cells was measured by Cell Counting Kit-8 assay (b). Control, normal glucose; CHG, constant high glucose; IHG, intermittent high glucose. Each bar represents the mean ± S.D. \**P* \< 0.05 and ^Δ^ *P* \< 0.05, respectively, indicate a significant difference from controls and CHG.](JDR2014-712781.003){#fig3}

![Determination of cell cycle with flow cytometry. After the treatment for 7 days, cells were collected for the detection of cell cycle according to the standard protocol. The distribution of cells in the different cell cycle phases was analyzed using Multicycle software. Data were expressed as mean ± SD of three determinations. Control, normal glucose; CHG, constant high glucose; IHG, intermittent high glucose. \**P* \< 0.05, and ^Δ^ *P* \< 0.05 respectively, indicate a significant difference from controls and CHG.](JDR2014-712781.004){#fig4}

![Expressions of cyclinD1, Skp2, p21, and p27 protein level in INS-1 cells were measured by Western blot analyses. Control, normal glucose; CHG, constant high glucose; IHG, intermittent high glucose. Data were expressed as mean ± SD. \**P* \< 0.05 and ^Δ^ *P* \< 0.05, respectively, indicate a significant difference from controls and CHG.](JDR2014-712781.005){#fig5}
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